Home » Psychology news » Anti-inflammatory therapy shows promise in slowing progression of multiple sclerosis
Anti-inflammatory therapy shows promise in slowing progression of multiple sclerosis
October 20, 2020 by NewsBot
Intranasal administration of an anti-inflammatory drug helped reduce disease progression in a preclinical model of multiple sclerosis, according to recent research.